(Total Views: 404)
Posted On: 03/17/2020 11:29:43 AM
Post# of 148936
Re: Rubraquercus #21835
Again, like every other company they've got a couple of weeks to list the trial AFTER firstpatient injected.
Again, they take their time/work to make everything in the BLA exactly like FDA liked in order to avoid a CRL/decline of application.
Since leronlimab is safe and highly effacious, only manufacturing could be an issue, but AGC is a decent company and they took their time.
So, once BLA is submitted, 5% chance it gets rejected IMO.
Again, they take their time/work to make everything in the BLA exactly like FDA liked in order to avoid a CRL/decline of application.
Since leronlimab is safe and highly effacious, only manufacturing could be an issue, but AGC is a decent company and they took their time.
So, once BLA is submitted, 5% chance it gets rejected IMO.
(4)
(0)Scroll down for more posts ▼
